![Chun-Soo Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chun-Soo Lee worked at Aprogen Biologics, Inc. as Chief Executive Officer, President & Director in 2011.
Mr. Lee served as President & Director at MOA Life Plus Co., Ltd. from 2021 to 2023.
| Unternehmen | Position | Ende |
|---|---|---|
| MOA LIFE PLUS CO. LTD. | Präsident | 29.12.2023 |
| APROGEN BIOLOGICS INC. | Vorstandsvorsitzender | 05.03.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Aprogen Biologics, Inc.
 Aprogen Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
MOA Life Plus Co., Ltd.
 MOA Life Plus Co., Ltd. BiotechnologyHealth Technology Operates as a holding company that engages in the development of biopharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
